Future Medicine is a privately owned company based in
London, England, United Kingdom. It is part of Future Science Publishing Group, primarily to publish
peer-reviewed
Peer review is the evaluation of work by one or more people with similar competencies as the producers of the work (peers). It functions as a form of self-regulation by qualified members of a profession within the relevant field. Peer review ...
medical journals. Future Medicine publishes
hybrid and
full open access journals.
Business model
Future Medicine publishes
open access
Open access (OA) is a set of principles and a range of practices through which research outputs are distributed online, free of access charges or other barriers. With open access strictly defined (according to the 2001 definition), or libre op ...
or
subscription
The subscription business model is a business model in which a customer must pay a recurring price at regular intervals for access to a product or service. The model was pioneered by publishers of books and periodicals in the 17th century, and ...
journals, which are owned by the respective societies they serve. The open access journals require authors to pay an
article processing charge. The company also provides an accelerated publication option, with speedy processing and publication of accepted articles within 6 weeks of submission.
Journals
In 2016, the company sold several of its journals to
OMICS Publishing Group
OMICS Publishing Group is a predatory publisher of open access academic journals. It started publishing its first journal in 2008. By 2015, it claimed over 700 journals, although about half of them were defunct. Its subsidiaries and brands in ...
, who moved them to
Pulsus Group, a company they recently acquired. OMICS is widely regarded as predatory publisher.
[Jocelyn Kaiser]
"ScienceInsi